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Dosage, Threshold, and Duration 
of ECT 
To the Editor: 
The article by Sackeim et al. (1987) entitled “Studies 
of Dosage. Seizure Threshold, and Seizure Duration 
in ECT” is one of the most stimulating articles on 
ECT I have read in recent times. Nevertheless, the 
research methodology used in the paper and the con- 
clusions proposed by the authors need clarification. 
viz: 
The inclusion criteria for the study was a 24-item 
Hamilton Depression Rating of 18 or more points, 
which is a relatively low HRSD score for an ECT 
cohort. The authors state that there were no dif- 
ferences in the Hamilton Depression scores be- 
tween the unilateral and bilateral trea~ent groups, 
but present only the overall mean (HRSD 31.09 
t 7.76). It would be of interest to know the actual 
mean data per group and whether baseline differ- 
ence could explain some of the outcome vari- 
ability noted in the unilateral group. 
How did the authors define treatment response? 
Was it done on a clinical basis or did they use 
Hamilton Depression criteria? Definitions for 
treatment response were not given in the descrip- 
tion of the methods. 
The authors alfowed the use of pm iorazepam up 
to 1 mg b.i.d. Like other ~n~~~azepines, it is 
welJ known for its antiseizure effects. The use of 
benzodiazepines during ECT has been associated 
with failure to induce seizures and shorter seizure 
duration, both of which contribute to poor treat- 
ment outcome with ECT (d’Elia et al. 1983). Lor- 
azepam has a half-life between 12 and 20 hr, and 
thus shows a lesser tendency to accumulate in 
patients; in aged patients, who are not infrequently 
referred for ECT, accumulation could occur (Shader 
and Greenblat, 1981). Was the intake of loraze- 
pam, number of doses, and period of use different 
between the unilateral and bilateral groups‘? Did 
the authors correlate seizure threshold and seizure 
duration with lorazepam use? Could the authors 
reanalyze their main conclusions in a group of 
patients free from lorazepam? The inhibitor ef- 
fects of benzodiazepines might be exaggerated by 
the method of titration used by the authors. 
4 The authors did not discuss the indjcations for 
referring these patients for ECT. Were these pa- 
tients medication nonresponders or was ECT cho- 
sen as the initial treatment modality‘? Even though 
it is not customary to estabfish this difference. in 
our experience the response to ECT is greater in 
those patients in whom ECT is the initial treatment 
modality. Were both groups. unilateral and bifat- 
eral, comparable with regard to the number of 
previous medication noI~responder patients? 
S. Did the authors compare cognitive functions pre- 
and post-ECT? Were unilateral-bifateral differ- 
ences found? 
The dramatically greater clinical efficacy of’ bi- 
lateral ECT described by the authors is puzzling. 
Many clinicians prescribe unilateral ECT under the 
assumption that it is as effective as bilateral EC’T, 
even though the unifateraf course may consist of more 
treatments. Bilateral electrode placement has been 
associated with more complaints of post-ECT cog- 
nitive abno~aiities, which may persist for some 
months after the course of ECT. The conclusions of 
the paper by Sackeim et at. may have a great impact 
on these assumptions. Therefore. rn~t~~odol~~gicai pu- 
rity is of great relevance. 
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To the Editor: for ECT would facilitate both the research and the 
communication of research findings. Sackeim and colleagues are to be congratulated 
for the wealth of information reported in their recent 
paper (1987). Using a MECTA instrument, they dem- 
onstrated clinically that the units of charge are a better 
indicator of the electrostimulatory dose than the er- 
gometric units, watt seconds or joules commonly used 
to indicate the dose in electroconvulsive therapy (ECT). 
Strictly speaking, this is incorrect. They did not spec- 
ify the type of MECTA instrument, but they specified 
that bidirectional pulse current was used. In alter- 
nating current, the net charge is close to zero re- 
gardless of the current duration, as each pulse of half- 
wave negates the charge of the previous one. To avoid 
this problem, one has to use a function of the absolute 
value of the charge (which Sackeim et al. seem to 
have done), or to square the current, as the stimulus 
energy increases with the square of the current. Gor- 
don ( 198 I) discussed the problems inherent in both 
methods of ECT dosimetry and suggested the re- 
cording of all parameters (voltage, current, joules, 
coulombs). In our experiments (Hyrman et al. 1985), 
we have also used units of charge, millicoulombs, to 
represent the dose with unidirectional pulses. This 
was quite adequate as long as the current remained 
constant. However. for comparison of various current 
patterns in ECT, we proposed a standard electrosti- 
mulatory dose unit (ESD) that would be arrived at 
using the formula: 
I/. Hyman 
Department of Psychiatry 
Royal Columbian Hospital 
260 Sherbrooke Street 
New Westminster, B.C. 
V3L 3W7 Canada 
References 
Hyrman V, Palmer LH, Cemik J, Jetelina J (1985): ECT: 
The search for the perfect stimulus. Bid Psychiatry 
20:634-645. 
Sackeim HA, Decina P, Portnoy S, Neeley P, Malitz S 
(1987): Studies of dosage, seizure threshold, and seizure 
duration in ECT. Bid Psychiatry 22:249-268. 
Response 
To the Editor: 
ESD = I? dr (k) 
where I denotes the current in amps and dt the dif- 
ferential time. The constant k = 1000 is used in order 
to arrive at units of convenient size. The average 
treatment dose with sine wave instrumentation would 
be about 500 ESD units, and a brief pulse machine, 
such as MECTA, would require a dose of about 200 
units. The Ultra Low Energy ECT instrument 
(ULEECTA), promoted by this writer, is calibrated 
in ESD units. In an l8-month clinical trial, the av- 
erage dose is in the neighborhood of 50 ESD units. 
I thank Drs. Grunhaus and Hyrman for their kind 
remarks about our paper, “Studies of Dosage, Seizure 
Threshold, and Seizure Duration in ECT” (Sackeim 
et al. 1987a). Space limitations prevent detailed re- 
sponse to each of the requests for additional infor- 
mation. In any case, most of the requested details 
have been provided in prior publications and in papers 
that are in press (Malitz et al. 1986; Sackeim et al. 
l986a, 1986b. 1987b. 1987c, 1987d; Steif et al. 1986). 
The queries raised by Dr. Grunhaus will be responded 
to first. 
More research is needed to clarify the effects of 
the ECT stimulus; adopting a standard dosimetric unit 
1. The sample was mostly composed of patients with 
severe, recurrent depressive episodes. Of 52 pa- 
tients, 42 (81%) had pretreatment HRSD scores 
of 25 or greater. The mean pretreatment score was 
3 I .54 (SD 8.37) in the unilateral right ECT group 
and 30.68 (SD 6.97) in the bilateral ECT group, 
a nonsignificant difference. Pretreatment scores 
were not associated with posttreatment scores, r(50) 
= 0.05, NS (Malitz et al. 1986; Sackeim et al. 
